By outsourcing mainstream cloning-to-production activities to us, pharma and biotech R&D teams can maximise their efficiency, reduce capital expenditure and tap into the specialised knowledge and technology that are necessary to guarantee success.
Our technology base covers all the requirements for antibody generation, cloning, modification and expression through to pilot-scale production for every conceivable antibody project, including:
- A wide choice of antibody vectors for efficient production in mammalian cells, covering most isotypes and species – so we can readily select or adapt them to suit your particular needs.
- An established, reliable phage display platform that guarantees the generation of a recombinant antibody for any peptide or protein antigen target.
- Tried and tested B-cell enrichment protocols for poorly immunogenic targets.
- Highly efficient electrofusion technique, vaccination protocols and ClonePix FL high throughput screening/selection procedures for efficient, cost effective hybridoma production.
- A broad selection of antibody production systems, so we can deliver single small batches for discrete projects or a steady supply for longer-running programs.
If you have an antibody project or program that you think could benefit from our technologies and expertise, please get in touch.
Connect With Us
